<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>G. glabra</italic> extracts have shown cardioprotective properties both 
 <italic>in vitro</italic> and 
 <italic>in vivo via</italic> the improvement of endogenous antioxidant defense mechanisms (
 <xref rid="B103" ref-type="bibr">Ojha et al., 2013</xref>; 
 <xref rid="B146" ref-type="bibr">Upadhyay et al., 2020</xref>). In DOX-induced toxicity in cardiomyocytes, licorice aqueous extract has improved sirtuin (SIRT)-1, a cardioprotective transcription factor, and its downstream proteins, peroxisomes proliferator-activated receptors (PPAR)-α/γ (
 <xref rid="B146" ref-type="bibr">Upadhyay et al., 2020</xref>). Glycyrrhizic acid has demonstrated an inhibitory effect on the long-lasting (L)-type calcium channels of cardiomyocytes. Although this compound could prevent calcium overload in ISO-induced cardiotoxicity, its potency was lower than verapamil even at the highest (20 mg/kg) dose (
 <xref rid="B76" ref-type="bibr">Li et al., 2019</xref>). Both hydroethanolic licorice extract and glycyrrhizic acid decreased the release of CK-MB and LDH, two indicators of myocardial damage (
 <xref rid="B103" ref-type="bibr">Ojha et al., 2013</xref>; 
 <xref rid="B76" ref-type="bibr">Li et al., 2019</xref>).
</p>
